MRNA vs UPXI · rev $145.0M vs P/E 1.8, rev $15.8M
Moderna Inc (MRNA) versus Upexi Inc. (UPXI) — a side-by-side from cached financials, not a winner call.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stéphane Bancel M.B.A..
Upexi Inc. (UPXI) is a internet content & information company listed on NASDAQ.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
Latest reported UPXI revenue for 2025-06-30 was $15.8M. Net income was -$13.7M. UPXI currently screens at market cap $65.3M and trailing P/E 1.8.
MRNA currently screens at market cap $24.52B. UPXI currently screens at market cap $65.3M and trailing P/E 1.8.
Not investment advice. Open the MRNA and UPXI stock pages for the full models.
Not investment advice.